Potentially agree - but why wouldn’t the company consider a back to back of the PO with a bona fide drawdown facility or some sort of debt factoring facility without the dilution caused by another CR?
- Forums
- ASX - By Stock
- GMV
- Ann: Notice of Annual General Meeting
Ann: Notice of Annual General Meeting, page-30
-
- There are more pages in this discussion • 423 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online